Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice.
(Q40231694)
scientific article published on 20 March 2007
scientific article published on 20 March 2007
Language:
Current Data About
Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice.